Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment.
Lin F, Yin S, Zhang Z, Yu Y, Fang H, Liang Z, Zhu R, Zhou H, Li J, Cao K, Guo W, Qin S, Zhang Y, Lu C, Li H, Liu S, Zhang H, Ye B, Lin J, Li Y, Kang X, Xi JJ, Chen PR.
Lin F, et al. Among authors: chen pr.
Cell. 2024 Nov 2:S0092-8674(24)01198-X. doi: 10.1016/j.cell.2024.10.016. Online ahead of print.
Cell. 2024.
PMID: 39504957